Fasciola hepaticacalcium binding protein FhCaBP2: Structure of the dynein light chain-like domain by Nguyen, Thanh H. et al.
1 
 
SHORT COMMUNICATION 1 
Fasciola hepatica calcium binding protein FhCaBP2: Structure of the 2 
dynein light chain-like domain 3 
 4 
Thanh H. Nguyen1,2, Charlotte M. Thomas3,4, David J. Timson3,5 and Mark J. van Raaij1 5 
1Dpto de Estructura de Macromoleculas, Centro Nacional de Biotecnologia - CSIC, calle Darwin 3, E-28049 6 
Madrid, Spain. 7 
2Genetic Engineering Laboratory, Institute of Biotechnology (IBT-VAST), 18 Hoang Quoc Viet, Cau Giay, 8 
Hanoi, Vietnam. 9 
3School of Biological Sciences, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, 10 
BT9 7BL, UK. 11 
4Institute for Global Food Security, Queen’s University Belfast, 18-30 Malone Road, Belfast, BT9 5BN, UK. 12 
5School of Pharmacy and Biomolecular Sciences, University of Brighton, Huxley Building, Lewes Road 13 
Brighton BN2 4GJ, UK. 14 
 15 
Running title: FhCaBP2 structure 16 
 17 
Acknowledgements Crystallographic data was collected at beamline XALOC-BL13 at ALBA 18 
Synchrotron Light Facility with the collaboration of Fernando Gil and Jordi Juanhuix. MJvR thanks the Spanish 19 
Ministry of Economy and Competitiveness for grants BFU2011-24843 and BFU2014-53425-P. THN received a 20 
PhD fellowship from the Consejo Superior de Investigaciones Científicas and Vietnam Academy of Science and 21 
Technology. CMT is in receipt of a PhD studentship from the Department of Employment and Learning, 22 
Northern Ireland (DELNI, UK). 23 
24 
Manuscript Click here to download Manuscript FhCaBPstrucpaper-
revised.docx
Click here to view linked References
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
2 
 
Abstract The common liver fluke Fasciola hepatica causes an increasing burden on human and animal 25 
health, partly because of the spread of drug resistant isolates. As a consequence there is considerable interest in 26 
developing new drugs to combat liver fluke infections. A group of potential targets is a family of calcium 27 
binding proteins which combine an N-terminal domain with two EF-hand motifs and a C-terminal domain with 28 
predicted similarity to dynein light chains (DLC-like domain). The function of these proteins is unknown, 29 
although in several species they have been localised to the tegument, an important structure at the host-parasite 30 
interface. Here, we report the x-ray crystal structure of the DLC-like domain of FhCaBP2 (Fasciola hepatica 31 
calcium binding protein 2), solved using single-wavelength anomalous diffraction and refined at 2.3 Å 32 
resolution in two different crystal forms. The FhCaBP2 DLC-like domain has a structure similar to other DLC 33 
domains, with an anti-parallel β-sheet packed against an α-helical hairpin. Like other DLC domains, it dimerizes 34 
through its 2-strand, which extends in an arch and forms the fifth strand in an extended β-sheet of the other 35 
monomer. The structure provides molecular details of the dimerization of FhCaBP2, the first example from this 36 
family of parasite proteins. 37 
 38 
Keywords Liver fluke · Calcium-Binding Protein · Dynein Light Chain · Crystal Structure · Helminth 39 
Protein 40 
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Introduction 42 
Parasitic infections from worms of the class Trematoda are causing an increasing burden on human and animal 43 
health. For example, it is estimated that several million humans are infected with the common liver fluke 44 
Fasciola hepatica – and this zoonotic infection is classed by WHO as a neglected tropical disease (Robinson 45 
and Dalton 2009). Globally, the impact of F. hepatica infections of farm animals is estimated to result in several 46 
billions of dollars of agricultural losses per annum (Boray 1994; Schweizer et al. 2005). This increasing burden 47 
results partly because of the spread of drug resistant isolates of liver flukes. Resistance to triclabendazole, a 48 
generally safe and effective treatment for liver fluke infections, is now widespread in flukes which infect farm 49 
animals and the first incidences of humans infected with resistant flukes has also been reported (Cabada et al. 50 
2016; Gil et al. 2014; Winkelhagen et al. 2012). As a consequence, there is considerable interest in developing 51 
new drugs to combat liver fluke, and other trematode, infections. Much of this interest focuses on the 52 
identification of possible novel targets from these organisms. Proteins which are unique to trematodes, and not 53 
present in the host, are particularly attractive, since antagonism of these molecules is less likely to have 54 
detrimental effects on the host. 55 
 One such group of potential targets is a family of calcium binding proteins which combine an N-56 
terminal domain with two EF-hand motifs and a C-terminal domain with predicted similarity to dynein light 57 
chains (DLC-like domain) (Russell and Timson 2014; Thomas and Timson 2016). This combination of domains 58 
is unique: no mammalian proteins with EF-hand and DLC-like domains in the same protein are known. The 59 
function of these proteins is unknown, and it is not known if the proteins are essential for infection or survival of 60 
the parasite (knock-out or RNAi studies on these proteins have not been reported). One family member 61 
(SmTAL3/Sm20.8 from Schistosoma mansoni) has been shown to form part of a high molecular mass protein 62 
complex together with dynein light chain; therefore, it has been postulated that its role may be to link calcium 63 
signalling with microtubule regulation (Hoffmann and Strand 1997). However, it should be noted that SmTAL3 64 
does not bind calcium ions, although other family members do (Thomas et al. 2015). In several species the 65 
family members have been localised to the tegument, suggesting a potential role in the regulation of this 66 
important structure at the host-parasite interface (Havercroft et al. 1990; Huang et al. 2007; Jeffs et al. 1991; 67 
Kim et al. 2012; Mohamed et al. 1998; Subpipattana et al. 2012; Vichasri-Grams et al. 2006; Xu et al. 2014; 68 
Zhang et al. 2012). In Schistosoma spp, there are typically large numbers of different family members 69 
expressed. For example, S. mansoni has at least 13 different members and several of these have been shown to 70 
illicit allergen-like IgE immune responses (Fitzsimmons et al. 2012). Consequently, these proteins are also 71 
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considered as possible vaccines as well as drug targets (Fitzsimmons et al. 2007; Fitzsimmons et al. 2004; 72 
Zhang et al. 2012). In F. hepatica, there are at least four family members (FH22, FhCaBP2, FhCaBP3 and 73 
FhCaBP4), with distinct biochemical properties (Banford et al. 2013; Orr et al. 2012; Ruiz de Eguino et al. 74 
1999; Thomas and Timson 2015). Similarly, the S. mansoni tegumental allergen (TAL) proteins that have been 75 
characterised biochemically show different drug and ion binding properties (Thomas et al. 2015). This suggests 76 
that each protein may have a subtly different function in the organism (Russell and Timson 2014; Thomas and 77 
Timson 2016). 78 
 A major barrier in understanding the biology of these proteins and in their possible development as 79 
vaccines or as drug targets is a lack of experimental, high-resolution structural data. To date, a number of 80 
molecular models have been reported but, like all models, these are highly reliant on the template structures 81 
(Banford et al. 2013; Orr et al. 2012; Thomas et al. 2015; Thomas and Timson 2015). Crystallization, but not 82 
structure solution, of the DLC-like domain of S. mansoni TAL2 (SmTAL2, Sm21.7) has also been reported 83 
(Costa et al. 2014). Here, we report the crystallographic structure of the DLC-like domain of FhCaBP2 84 
(UniProt: A0A0B5GUS3). 85 
 86 
Materials and Methods 87 
Purification and crystallisation of FhCaBP2 88 
Recombinant hexahistidine-tagged FhCaBP2 was expressed in Escherichia coli HMS174(DE3) and initial 89 
purification carried out using cobalt affinity resin as previously described (Thomas and Timson 2015). Further 90 
purification was conducted by anion-exchange chromatography (Resource Q6 column, GE-Healthcare 91 
Biosciences, Uppsala, Sweden), after dialysing the protein against 10 mM Tris-HCl pH 8.5, 1 mM dithiothreitol. 92 
The protein was eluted in the same buffer with a linear gradient of 0-0.65 M sodium chloride, and eluted in two 93 
adjacent peaks around 0.3 M. It is not clear what the difference is between the two peaks, because on SDS-94 
PAGE the same band is observed. Fractions containing pure protein from each peak were pooled separately and 95 
concentrated up to 16 mg/ml using an Amicon Ultra concentrator with a molecular weight cut-off of 10 kDa 96 
(Millipore, Billerica MA, USA). Three washes with 10 ml of 10 mM Tris-HCl pH 8.5, 50 mM sodium chloride 97 
were applied. The samples were stored at 4 °C prior to crystallization trials. 98 
 FhCaBP2 protein was crystallized using the sitting drop vapour diffusion method (MRC 2-well Swissci 99 
crystallization plates, Molecular Dimensions, Newmarket, UK), adding 50 l of precipitant solution to the 100 
reservoir wells. To form the drops, protein solution (0.2 l) was mixed with 0.2 l of the respective reservoir 101 
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solution (Genesis RSP 150 workstation; Tecan, Männedorf, Switzerland). Plates were incubated at 21 ºC. After 102 
two months of incubation, a crystal was obtained in each of two drops, one in the presence of 20 % (w/v) PEG 103 
3350 and 0.2 M sodium tartrate and one with the same precipitant and 0.2 M potassium citrate. To generate the 104 
heavy atom derivative crystal, a few grains of solid methylmercury chloride were added to the reservoir of a 105 
crystal grown in the presence of sodium tartrate. The drop was equilibrated overnight with the reservoir and 2 l 106 
of reservoir solution were then added to the drop and incubated for about 5 min. The native crystal and 107 
derivative crystal were harvested with a Litholoop (Molecular Dimensions, Newmarket, UK) and flash-cooled 108 
in liquid nitrogen without cryo-protection. 109 
 Six-histidine-tagged recombinant C-terminal domain (residues 99-189) was also expressed in E. coli as 110 
previously described (Thomas and Timson 2015). It was purified using the same protocol as described above for 111 
the full-length protein, in this case a single peak was observed after anion exchange chromatography, eluting at 112 
around 0.15 M sodium chloride. Crystallization of C-terminal domain protein was performed in the same 113 
manner as for the full-length protein, crystals were obtained within two weeks from the condition containing 20 114 
% (w/v) PEG 3350 and 0.2 M sodium tartrate. Crystals were harvested as above. 115 
 116 
X-ray crystallography data collection and structure solution 117 
Crystallographic data were collected from a methylmercury chloride derivative crystal at the BL13-XALOC 118 
beamline of the ALBA synchrotron (Juanhuix et al. 2014), using a wavelength at which significant anomalous 119 
signal from the added mercury atoms was expected (1.0056 Å). Crystallographic data were integrated using 120 
MOSFLM (Battye et al. 2011) and further processed using POINTLESS, SCALA and TRUNCATE (Evans 121 
2011) from the CCP4-suite (Winn et al. 2011) to obtain structure factor amplitudes. Structure solution was done 122 
using AUTOSHARP (Vonrhein et al. 2007), which employs SHELX for heavy atom substructure determination 123 
(Sheldrick 2010), SHARP for phase determination (de La Fortelle and Bricogne 1997), SOLOMON for solvent 124 
flattening (Abrahams and Leslie 1996) and ARPWARP for automated model building (Langer et al. 2008). The 125 
auto-traced model was completed using COOT (Emsley et al. 2010) and refined using REFMAC5 (Murshudov 126 
et al. 2011) (10% of reflections were selected for calculation of Rfree (Brunger 1993)). For structure solution of 127 
the non-derivatised C-terminal domain, data was also collected at BL13-XALOC. Structure solution by 128 
molecular replacement was performed using PHASER (McCoy et al. 2007), after increasing the number of 129 
allowed C-α clashes to 20%. The model was completed using COOT and refined using REFMAC5 as before. 130 
Validation was done with MOLPROBITY (Chen et al. 2010). Structure comparisons, including r.m.s.d. and Z-131 
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score calculations, were performed using the DALI server (Holm and Rosenstrom 2010). Figures were made 132 
using PyMol (The PyMol Molecular Graphics System, Version 1.5.0.4. Schrödinger, LLC). Protein assembly 133 
parameters were calculated using PISA (Krissinel and Henrick 2007) and the PIC server (Tina et al. 2007). Data 134 
collection, phasing and refinement parameters are shown in Table 1. 135 
 136 
Results and Discussion 137 
Structure of the DLC-like domain of FhCaBP2 138 
In initial experiments, we attempted to crystallise full length FhCaBP2 (residues 1-189). This resulted in the 139 
formation of single prism-shaped crystals (Figure 1A), belonging to space group P41212, with one protein 140 
molecule in the asymmetric unit. However, upon analysis, it became apparent that these crystals only contained 141 
the C-terminal DLC-like domain of the protein. Interestingly, a similar outcome was reported following 142 
attempts to crystallise SmTAL2 (Costa et al. 2014). This suggests that the flexible linker between the EF-hand 143 
domain and the DLC-like domain in these proteins is susceptible to degradation by proteases. Indeed, we 144 
speculate that this may be important in their normal, in vivo functioning. The complete absence of the EF-hand 145 
domain in the structure is interesting and may indicate that this domain is less stable to proteolysis than the 146 
DLC-like domain. Later, we also crystallized the C-terminal domain (residues 99-189) separately. In this case, 147 
crystals belonging to space group P6422 were obtained, also with one protein monomer in the asymmetric unit 148 
(Figure 1B). 149 
 A methylmercury chloride derivative of a crystal of the P41212 form was prepared and diffraction data 150 
were collected from it (Table 1). Three heavy atom sites were located, of which one was well-occupied and later 151 
modelled as a mercury ion between cysteine residues 153 and 181. Single-wavelength anomalous dispersion led 152 
to good phases, which were used in an automatic model building procedure to yield a protein model with 97 153 
residues (Ala92 to Arg188; the entire C-terminal DLC-like domain plus a few residues of the linker between the 154 
N-terminal EF-hand domain and C-terminal DLC-like domain). Careful refinement at 2.3 Å resolution and 155 
inspection of electron density maps allowed the addition of a mercury ion, two chloride ions and 57 water 156 
molecules (PDB code 5FWZ). Using this structure, the structure of a native crystal of the P6422 space group 157 
was solved by molecular replacement and refined to 2.3 Å resolution. The final model of this structure contains 158 
89 amino acids, Ile99 to Pro187, plus nine residues of the N-terminal expression tag and eight water molecules 159 
(PDB code 5FX0). The packing of the molecules in the two crystal forms is very different, apart from the dimer 160 
interaction described below. The two structures of the DLC-domain are identical in the two crystal forms; a root 161 
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mean squared deviation (r.m.s.d) of only 0.5 Å is obtained when the C-α atoms of residues 99-187 are 162 
superposed. 163 
 The structure of the DLC-like domain revealed a compact, largely β-sheet structure (Figure 2). It 164 
consists of an anti-parallel β-sheet packed against a hairpin of α-helices (Figure 2A). The order of the β-strands 165 
is 0341 and the 12 hairpin is between strands 0 and 1 in the primary sequence. The structure is similar to 166 
many of the DLC domains in the PDB database. They can be superimposed with an r.m.s.d. of 1.5-2.0 Å (81-85 167 
superposed residues, DALI Z-scores between 13 and 14). Although Cys153 and Cys181 are physically close to 168 
each other, no cystine bond is observed between them. Cystine bonds are also not observed in other DLC-like 169 
domains (for example in PDB entries 1CMI, 3E2B or 4DS1 (Benison et al. 2008; Liang et al. 1999; Romes et al. 170 
2012)). Two cis-peptides are observed in the structure, Ala92-Pro93 (in the putative linker between the N- and 171 
C-terminal domains) and Arg149-Val150, a non-proline cis-peptide. Non-proline cis-peptides are rare, but the 172 
observed electron density clearly indicates their presence in this case. The experimental structure is in good 173 
agreement with the DLC-like domain of the previously published molecular model (Thomas and Timson 2015); 174 
residues 99-187 can be superposed with an rmsd of 2.7 Å (Figure 3A). Significant differences are only observed 175 
for the inter-domain linker, the loop between 1 and 2, strand 2 and the very C-terminal residues. The model 176 
was of a monomeric protein and so this structure enables us to understand, for the first time, the molecular basis 177 
of dimerization in these proteins. 178 
 179 
Dimer interactions 180 
The DLC-like domain of FhCaBP2 dimerises through an extended β-sheet structure (Figure 2). The interface is 181 
largely composed of the β2-strand from each subunit, bent through almost 180° into an arch. Strand 2 protrudes 182 
from the back of the molecule and interacts with strand 1 of another monomer to form a symmetric dimer (i.e., 183 
the dimer contains β-sheets 03412' and 0'3'4'1'2; Figure 2B). In both crystal forms, the same 184 
crystallographic dimer is observed, with an inter-monomer interface of about 1100 Å2 and an estimated 185 
dissociation energy of approximately 15 kcal.mol-1. Key residues in the interaction are those belonging to the 1- 186 
and 2-strands, five main-chain hydrogen bonds hold together each of the extended β-sheets. Side-chains of 187 
residues of the same strands also contribute to the hydrophobic interaction interface. Further hydrophobic 188 
interactions are formed between residues of the 2-strand and the 2-helix and between opposing 1-and 4-189 
strands. At least six additional hydrogen bonds involving side-chains are also present. Homo-dimer formation of 190 
the FhCaBP2 DLC-like domain is consistent with biochemical data (Thomas and Timson 2015) and identical to 191 
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known structures of DLC-like domains. This arrangement is also seen in DLC dimers from Saccharomyces 192 
cerevisiae (Dyn2p) (PDB 4DS1, Z-score 13.8, r.m.s.d. 1.8 Å2 when 84 C atoms are aligned; Romes et al. 193 
2012), in the rat 8 kDa DLC (PDB 1F3C; Z-score 10.3, r.m.s.d. 2.2 Å2 when 86 C atoms are aligned; Fan et al. 194 
2001) and in human dynein light chain 8 (PDB 3ZKE, Z-score 13.9, r.m.s.d. 1.6 Å2 when 83 C atoms are 195 
aligned; Gallego et al. 2013), albeit with somewhat smaller interaction surfaces (around 800 Å2) and predicted 196 
interaction energies (around 10 kcal.mol-1). While the conservation of the structural scaffold means that dimer 197 
interactions are almost identical in terms of main-chain hydrogen bonds, the low sequence identity between the 198 
FhCaBP2 DLC-like domain with the DLC domains mentioned above of around 20% means side-chain 199 
electrostatic interactions, hydrogen bonds and van der Waals interactions are very different. 200 
 In S. cerevisiae Dyn2p, peptides from the nuclear pore component Nup159p dock into the cleft 201 
between the two monomers of the DLC, further extending the β-sheet structure (Romes et al. 2012). Peptides 202 
from neuronal nitric oxide synthase (nNOS) and BCL2-like 11 (BIM, an apoptosis regulator) both bind into the 203 
cleft between the monomers in a similar arrangement to the Dyn2p-Nup159p interaction (PDB 1F95, 1F96 (Fan 204 
et al. 2001)). In human dynein light chain 8, peptides from the Nek7 protein kinase also bind to the same site 205 
(PDB 3ZKE, 3ZKF; Gallego et al. 2013). This demonstrates that a wide variety of different binding partners can 206 
interact with DLC dimers in this manner and suggests that FhCaBP2 (and other proteins from this family) may 207 
also exploit this mode of protein-protein interaction. A superposition of the FhCaBP2 DLC-like domain with the 208 
human dynein light chain 8 - Nek7 protein kinase peptide structure (Figure 3B) shows that, although the 209 
structures generally overlap very well, the 12-loop, 12-loop, 2-strand and 23-loop adopt somewhat 210 
different conformations (in S. cerevisiae Dyn2p and rat 8 kDa DLC, these secondary structure elements have a 211 
very similar conformation to that in human dynein light chain 8). In the superposition, the FhCaBP2 23-loop 212 
(highlighted with an arrow in Figure 3B) overlaps with the peptide, suggesting that the FhCaBP2 DLC-like 213 
domain, if it is involved in further protein-protein interactions, may need to change conformation to bind 214 
another protein or may bind its interaction partners in a somewhat different manner. 215 
 216 
Conclusions 217 
The structure reported here enables us to understand the dimerization of DLC-like domains of this class of 218 
proteins and validates the modelling techniques used to predict the structure of this domain in a range of 219 
proteins. It also suggests how this family of proteins might interact with other proteins through the DLC-like 220 
domain. The in vivo functions of this family of proteins remain enigmatic. However, it is hypothesised that they 221 
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may perform roles in calcium signalling in the tegument (Thomas and Timson 2016). If such a role is 222 
demonstrated then they would be very attractive targets for the development of novel anthelminthic drugs. One 223 
possible strategy would be the identification of molecules which disrupt dimer formation. This structure 224 
provides vital information to enable that process and the low sequence similarity in the dimerization region 225 
suggests that it should be possible to identify molecules which selectively target trematode proteins without 226 
affecting host DLCs.  227 
 228 
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Figure legends 347 
Fig. 1 Crystals of the dynein light chain-like domain of the Fasciola hepatica calcium-binding protein 2. a 348 
Crystal (about 0.2 x 0.15 x 0.1 mm) belonging to the P41212 spacegroup. b Crystal (about 0.45 x 0.2 x 0.2 mm) 349 
belonging to the P6422 spacegroup. 350 
 351 
Fig. 2 Structure of the DLC-like domain of FhCaBP2. a Monomer structure. The protein chain is coloured 352 
from blue (N-terminus) to red (C-terminus) in a rainbow colour scheme. β-Strands and α-helices are labelled. b 353 
Dimer structure. One monomer is coloured as in the previous panel, the other in cyan. Black arrows indicate 354 
where peptide interactions take place in other DLC domains. c Topology diagram of the dimer. Monomers are 355 
coloured as in the previous panel. 356 
 357 
Fig. 3 Comparison of the FhCaBP2 DLC-like domain with the modelled structure of the whole protein and 358 
with other DLC domains. a Superposition of the crystallographically determined structure of the FhCaBP2 359 
DLC-like domain (in green) and the previously published model of the entire structure (in magenta). The 360 
predicted calcium ion is shown in grey and the termini of the DLC-like domain are indicated. b Superposition of 361 
the FhCaBP2 DLC-like domain (in green) and human dynein light chain 8 (PDB entry 3ZKE, in blue). The 362 
peptide bound to human dynein light chain 8 is shown in yellow and the 23-loop is highlighted with an arrow. 363 
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Table 1 Crystallographic data collection, phase determination, solvent flattening and refinement statistics (all 
values in parenthesis are for the highest resolution bin). 
 
Data collection Derivative Native 
Space group P41212 P6422 
Unit cell dimensions (a, b, c) (Å)  59.9, 59.9, 81.3 57.9, 57.9, 90.0 
Wavelength (Å)  1.0056 1.0047 
Resolution (Å)  23.0-2.30 (2.42-2.30) 50.0-2.20 (2.32-2.20) 
Observed reflections 7026 (990) 5253 (726) 
Multiplicity 9.6 (9.7) 11.0 (11.7) 
Completeness (%) 99.9 (100.0) 100.0 (100.0) 
Rmerge (%) 11.7 (47.4) 5.7 (49.3) 
<I/sigma(I)> 12.0 (4.5) 22.7 (5.0) 
Wilson B (Å2)  30.9 41.2 
CC1/2 0.997 (0.929) 1.000 (0.969) 
CCanom 0.567 (0.015) -0.129 (0.049) 
Phase determination 
Number of heavy atom sites (Hg) 3 - 
Anomalous phasing power 1.185 - 
Figure of merit (acentric / centric) 0.315/0.137 - 
Solvent flattening (53.6% solvent) 
Hand score (original / inverted) 0.593 / 0.247 - 
Overall correlation on |E|2 / contrast 3.72 - 
Refinement 
Resolution range (Å)  23.0-2.30 (2.36-2.30) 50.0-2.30 (2.36-2.30) 
No. reflections used in refinement 6289 (445) 4093 (282) 
No. reflections used for R-free  702 (44) 484 (34) 
R-factor (%) 19.1 (23.0) 20.2 (29.6) 
R-free (%) 24.1 (26.3) 27.5 (49.4) 
Number of protein / Hg / Cl / solvent atoms  802 / 1 / 2 / 57 816 / 0 / 0 / 7 
Average B protein / Hg / Cl / solvent atoms (Å2) 37.0 / 48.4 / 62.3 / 40.4 63.1 / - / - / 55.1 
Ramachandran plot (favoured / allowed) (%) 99.0 / 100.0 97.9 / 100.0 
R.m.s. deviation of bonds (Å) and angles (º) 0.012 / 1.5 0.011 / 1.5 
PDB code 5FWZ 5FX0 
 
Table 1 Click here to download Table Table1.docx 
Figure 1 Click here to download Figure Fig1.tif 
Figure 2 Click here to download Figure Fig2.tif 
Figure 3 Click here to download Figure Fig3new.tiff 
